Efficacy and safety of an alpha 7-nicotinic acetylcholine receptor agonist, VQW-765, in subjects with performance anxiety: randomised, double-blind, placebo-controlled trial.

Br J Psychiatry · 2025 · PMC12278049 · PMID 40340771

Europe PMC DOI

hedged sentence

0.1443

closest p · 2.9× alpha

0.1443

boldest claim

The sentences

showed a trendP = 0.1443not close (p > 0.1)

Results Subjects receiving VQW-765 showed a trend of improvement in intensity of anxiety, as measured by the SUDS, during the performance phase of a TSST compared with placebo ( P = 0.1443).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.